ClinCalc Pro
Menu
Direct oral anticoagulant (DOAC) — Factor Xa inhibitor Pregnancy: Contraindicated — LMWH preferred in pregnancy.

Apixaban

Brand names: Eliquis

Adult dose

Dose: AF: 5 mg twice daily (2.5 mg BD if ≥2 of: age ≥80, weight ≤60 kg, creatinine ≥133 micromol/L); VTE: 10 mg BD for 7 days then 5 mg BD
Route: Oral
Frequency: Twice daily
Max: 10 mg twice daily (VTE initial); 5 mg twice daily (maintenance/AF)
AF (ARISTOTLE criteria): 5 mg BD; reduce to 2.5 mg BD if 2 or more of age ≥80, weight ≤60 kg, creatinine ≥133 mcmol/L. VTE: 10 mg BD for 7 days, then 5 mg BD (maintenance) or 2.5 mg BD (extended treatment). Post-arthroplasty: 2.5 mg BD for 32–38 days (hip) or 10–14 days (knee).

Paediatric dose

Route: Oral
Frequency: Twice daily
Max: Specialist guidance required
Paediatric VTE: specialist haematology guidance required. Weight-based dosing. Licensed in some paediatric VTE scenarios.

Dose adjustments

Renal

Reduce to 2.5 mg BD if AF + 2 criteria (age ≥80, weight ≤60 kg, creatinine ≥133). Avoid if eGFR <15.

Hepatic

Avoid in moderate-severe hepatic impairment.

Clinical pearls

  • Lowest GI bleeding risk among DOACs — preferred over rivaroxaban and dabigatran for GI bleeding risk
  • Twice-daily dosing provides more stable drug levels — better adherence essential
  • Can be crushed and dissolved in water (or apple juice) for administration via NG tube
  • ARISTOTLE trial: apixaban superior to warfarin for AF — fewer strokes, fewer bleeds, lower mortality
  • Reversal: andexanet alfa or 4-factor PCC

Contraindications

  • Active significant bleeding
  • Severe hepatic impairment
  • Pregnancy

Side effects

  • Bleeding (less GI bleeding than rivaroxaban or warfarin — ARISTOTLE trial)
  • Anaemia
  • Nausea
  • Elevated LFTs

Interactions

  • Strong CYP3A4 and P-gp inhibitors — increase apixaban levels
  • Strong CYP3A4 and P-gp inducers — reduce apixaban levels
  • Antiplatelet drugs and NSAIDs — increased bleeding

Monitoring

  • eGFR annually
  • LFTs
  • Haemoglobin
  • Signs of bleeding

Reference: BNFc; BNF; NICE NG196; ARISTOTLE trial; ESC AF Guidelines. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.